Art. 6 Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December…

Protocol assistance

In forcesince 7 Aug 2009cited 1×
1.

The sponsor of an orphan medicinal product may, prior to the submission of an application for marketing authorisation. request advice from the Agency on the conduct of the various tests and trials necessary to demonstrate the quality, safety and efficacy of the medicinal product, in accordance with Article 51(j) of Regulation (EEC) No 2309/93.

2.

The Agency shall draw up a procedure on the development of orphan medicinal products, covering regulatory assistance for the definition of the content of the application for authorisation within the meaning of Article 6 of Regulation (EEC) No 2309/93.

  • Judgment of the General Court (Sixth Chamber) of 28 October 2020. Pharma Mar, SA v European Commission.Decision

    With a view to making an application for marketing authorisation for Aplidin, the applicant sought and obtained from the European Medicines Agency (‘the EMA’), pursuant to Article 6(1) of Regulation No 141/2000, protocol assistance in …

    28 Oct 2020 · 62018TJ0594